You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study

 

Online download statistics by month:

Online download statistics by month: March 2018 to March 2024

AbstractFullPdf
Mar 2018888814
Apr 2018186188126
May 201819319465
Jun 201811912049
Jul 2018767631
Aug 201813613546
Sep 201813513531
Oct 201816216249
Nov 201818218349
Dec 201825825824
Jan 201918618337
Feb 201917417332
Mar 201914714221
Apr 2019706826
May 2019797831
Jun 2019908718
Jul 201913613424
Aug 2019777619
Sep 2019393915
Oct 2019433814
Nov 2019201913
Dec 2019696810
Jan 2020444416
Feb 2020353311
Mar 2020454315
Apr 2020302813
May 2020303017
Jun 202023218
Jul 202031289
Aug 2020292714
Sep 202013413216
Oct 2020343337
Nov 2020332818
Dec 202018189
Jan 202116164
Feb 2021141219
Mar 2021272415
Apr 2021312610
May 2021262313
Jun 2021342916
Jul 2021302714
Aug 2021211619
Sep 2021131310
Oct 2021312936
Nov 2021302423
Dec 2021524912
Jan 202227269
Feb 2022202110
Mar 2022282817
Apr 2022242314
May 2022373719
Jun 2022444315
Jul 2022686610
Aug 202250508
Sep 2022333010
Oct 2022383511
Nov 2022323113
Dec 202236345
Jan 2023444619
Feb 202349453
Mar 202331319
Apr 202332329
May 2023252311
Jun 2023494912
Jul 2023535211
Aug 202359564
Sep 202364613
Oct 202362552
Nov 202381805
Dec 2023656511
Jan 2024545113
Feb 2024644811
Mar 2024797630
Total472445911412